Results 101 to 110 of about 7,439 (222)

Kinetik und Mechanismus der selektiven Bindung von Ionen durch Cyclodepsipeptid-Antibiotika

CHIMIA, 1972
Stability constants for cation complexes of valinomycin and enniatin B were determined in methanol employing spectrophotometric titrations. Kinetic studies by relaxation methods led to the elucidation of the reaction mechanism of complex formation ...
Th. Funck, F. Eggers, E. Grell
doaj   +1 more source

Total Synthesis of Cyclodepsipeptide Xylaroamide A

Chemistry
Cyclodepsipeptides constitute a structurally diverse class of natural products composed of amino acid and hydroxy acid residues interconnected through both amide and ester bonds.
Rongping Wu, Dongping Qiu, Yogini S. Jaiswal, Xinrong Xie, Leonard L. Williams, Yu Fan, Hedong Bian, Yifu Guan, Shaoyang Su   +8 more
doaj   +1 more source

Konformationsanalyse und Kinetik der Konformationsänderungen von membranaktiven Antibiotika

CHIMIA, 1972
Molecular properties of the membrane active antibiotics enniatin B, valinomycin and gramicidin A were investigated in various solvents. The conformational rearrangements of these antibiotics have been studied as a function of solvent polarity by ...
E. Grell, F. Eggers, Th. Funck
doaj   +1 more source

Kahalalide K:  A New Cyclic Depsipeptide from the Hawaiian Green Alga Bryopsis Species

, 2016
Kahalalide K (1), a new cyclic depsipeptide, was isolated from the Hawaiian green alga Bryopsis sp. Kahalalide K was determined to possess a new array of three l- and three d-amino acids, including a 3-hydroxy-9-methyldecanoic acid that had been ...
Bryan Sakamoto (2348320), Yukiko Kan (2278276), Tsuyoshi Fujita (263131), Yoshitsugi Hokama (3061884), Hiroshi Nagai (470413)   +4 more
core   +1 more source

Clovibactin and Staphylococcus aureus: a new weapon against resistant strains

GMS Hygiene and Infection Control
Clovibactin is a new depsipeptide and highly efficacious against () , including methicillin-resistant and vancomycin-resistant , with no apparent resistance. Clovibactutclasses current antibiotics such as vancomycin.
Adeiza, Shuaibu Suleiman
doaj   +1 more source

Depsipeptide Methodology for Solid-Phase Peptide Synthesis:  Circumventing Side Reactions and Development of an Automated Technique via Depsidipeptide Units^†,‡

, 2016
The depsipeptide technique is a recently developed method for peptide synthesis which is applicable to difficult sequences when the synthetic difficulty arises because of aggregation phenomena.
Michael Bienert (2355265), Eberhard Krause (245266), Calin Dan Sferdean (2532814), Rudolf Dölling (2532817), Louis A. Carpino (2355259), Irene Coin (2062345), Michael Beyermann (711881)   +6 more
core   +1 more source

Kulokekahilide-2, a Cytotoxic Depsipeptide from a Cephalaspidean Mollusk Philinopsis speciosa^†

, 2016
A cytotoxic depsipeptide, kulokekahilide-2 (1), was isolated from a cephalaspidean mollusk, Philinopsis speciosa. The structure elucidation of kulokekahilide-2 was carried out by spectroscopic analysis and chemical degradation.
Wesley Y. Yoshida (1265682), Liu Yang (23752), Yoichi Nakao (1605271), Yuuki Takada (2709382), Junji Kimura (2709379), Paul J. Scheuer (2709376), Susan L. Mooberry (665537)   +6 more
core   +1 more source

Rivastigmine-Loaded L-Lactide-Depsipeptide Polymeric Nanoparticles: Decisive Formulation Variable Optimization

, 2013
The main aim of the investigation was to explore a novel L-lactide-depsipeptide copolymer for the development of rivastigmine-loaded polymeric nanoparticles.
Pradeep VAVIA, Kunal PAGAR
core   +1 more source

Georgamide, a New Cyclic Depsipeptide with an Alkynoic Acid Residue from an Australian Cyanobacterium

, 2016
A cyclic depsipeptide, georgamide (1), was isolated from an Australian cyanobacterium and characterized by spectroscopic means. The constituent units were five amino acid residues, one each of l-Thr, l-Pro, l-Val, N-Me-l-Val, and N-Me-l-Phe, and two ...
Karen L. Erickson (2254336), Feng Wan (565437)   +1 more
core   +1 more source

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Biologics: Targets & Therapy, 2013
Katherine Ververis,1 Alison Hiong,1 Tom C Karagiannis,1,* Paul V Licciardi2,*1Epigenomic Medicine, Alfred Medical Research and Education Precinct, 2Allergy and Immune Disorders, Murdoch Childrens Research Institute, Melbourne, VIC, Australia*These ...
Ververis K, Hiong A, Karagiannis TC, Licciardi PV   +3 more
doaj